ASML's reported inability to make enough machines for the next two years is a buy signal for the whole AI stack. Its stock still sold off despite that shortage. x.com 

Lam Research's record results suggest the equipment cycle is not ending despite its stock selloff. Revenue reached $8.22B, up 54% year over year and over 20% sequentially, while EPS rose 75%; ASML and TSMC also report customers needing more tools. Overweight with a $355 target and 35% upside, but the selloff is a gift only if Lam guides December higher. x.com  x.com 

ASML's planned 2027-28 output cannot meet customer demand, supporting a Buy rating and €1,830 target. Long-term customer down payments rose from €3.6bn to €9.3bn; customers seek 2029-30 orders that ASML has not accepted. Critical-tool price rises begin in 2027, with full effect in 2028, but are not meant to recur annually. Q3 EPS excluding a €509.7m investment gain still beat consensus. x.com  x.com  x.com  x.com  x.com 

ASML faces moat erosion now that China has a homegrown alternative to its machines. The Information reports a state-backed Shanghai company has started mass-producing DUV lithography tools. Chinese fabs stockpiling older DUV tools had become a major revenue driver, with China at 36% of sales in 2024 and 29% last year. Output is tiny, about five machines this year and maybe twenty next. But once a second supplier exists, the question shifts from "no alternative" to "for how long." x.com 

Rising AI equipment demand could sustain the buildout behind Micron, Nebius, Marvell, Bloom Energy and Applied Optoelectronics. ASML says customers are raising short- and medium-term forecasts, some are interested in orders for 2029 or 2030, and its currently planned 2027-28 supply may not fully meet demand. The dip in these AI stocks might be a buying opportunity. x.com 

ASML's EUV R&D is starting to pay off through operating leverage. Q3 R&D fell as a share of sales, though one quarter is not a trend. Higher units, IBM sales and EUV/DUV prices put 2028 estimates well above the 2030 guide and ahead of consensus; shares look cheap at €1,530. Assuming 30% prepayment, liabilities imply €42-45bn of orders in 2026's first nine months, subject to invoicing lags. The proposed MATCH Act could restrict China sales; 2029-30 demand is less certain than 2028. x.com  x.com  … Show more

ASML lacks the growth it needs, even though @mzuhair123 makes a good case that High-NA going mainstream by decade-end will strengthen its Dutch hegemony. x.com 

Semiconductor trade faces a capex growth ceiling even if AI delivers what bulls expect. Spending cannot compound at 70-100% a year indefinitely, and compute per dollar roughly doubles every two years, so the same budget buys more capacity later. Today's chip valuations also demand years of 20% AI earnings growth beyond 2028: roughly 10.9 extra years for AMD, 8.9 for ASML, 7 for Marvell and 6.4 for TSMC, versus 1.6 for Broadcom and 0.8 for Nvidia; Micron needs none under the chart's assumptions. … Show more

ASML's blowout results undercut the bearish AI case, and the chip selloff that followed is a sell-the-news valuation correction, not a demand problem. Revenue of €9.326 billion beat by 5%, EPS by 10%, gross margin hit 54%, full-year guidance rose 16% and 2026-2028 shipments were raised. Oversupply fears from heavy tool orders look overdone, since tools take a long time to reach production and capacity doesn't translate linearly into qualified chips. JPMorgan sees 2028 EPS possibly above €65. … Show more

Requests for ASML lithography-tool slots as far out as 2030 signal years of locked-in downstream AI infrastructure spending plans. ASML's machines come before the chips, making those customer requests a clearer early demand signal than chip headlines. x.com